Asthma, Inc Clinical Research Center

Seattle, Washington 98115-2024

0 studies enrolling now · 9 studies all time

What they study most

Asthma, Cat Allergy, Cat Hypersensitivity, Chronic Idiopathic Urticaria, Peanut Allergy, Perennial Allergic Rhinitis

Studies at this site

• Longer-term Study of AR101 in Subjects Who Participated in a Prior AR101 Study (ARC008) — Completed
• Study to Investigate Etokimab (ANB020) Activity in Adult Participants With Peanut Allergy — Completed
• PALISADE Follow-on Study (ARC004) — Completed
• AR101 Real-World Open-Label Extension Study — Completed
• Real-World AR101 Market-Supporting Experience Study in Peanut-Allergic Children (RAMSES) — Completed
• Anti-TSLP (AMG 157) Plus Antigen-Specific Immunotherapy for Induction of Tolerance in Individuals With Cat Allergy — Completed
• Three-month, Single-center Study to Identify Biomarkers/Response to Xolair Therapy in Chronic Idiopathic Urticaria — Completed
• Evaluation of Efficacy and Safety for Single Dose of E004 in Children With Asthma — Completed
• A 6 Month Safety Study Of Ciclesonide Nasal Aerosol (Zetonna®) And Ciclesonide Nasal Spray (Omnaris®) In Subjects 12 Years And Older With Perennial Allergic Rhinitis (PAR) — Completed